CONVENTION RESOLUTIONS 15TH NATIONAL CONVENTION RENO, NEVADA AUGUST 17-21, 2011 HEALTH CARE VETERANS HEALTH CARE History: First adopted in 1983 as V-9-83 Amended in 1987 as V-5-87 Amended in 1989 as V-4-89 Amended in 1991 as V-1-91 Amended in 1993 as V-1-93 Amended in 1995 as V-1-95 Amended in 1997 as V-1-97 Renumbered in 2003 as HC-1-03 Amended in 2005 as HC-1-05 Amended and renumbered in 2007 as V-1-05 Amended and renumbered in 2011 as HC-2 Issue: The Department of Veterans Affairs (DVA) Veterans Health Care Administration, Veterans Integrated System Network/VISN, is responsible for providing health care to veterans with service-connected disabilities and others as determined by eligibility rules established by Congress. Concerns continue regarding quality of health care, access, and eligibility for services. Background: Many veterans have been adversely affected by what has been described as a health-care system “in crisis.” This, in part, is due to budget and resource limitations. Other significant factors are directly related to the massive size of the centralized DVA healthcare system, its bureaucratic inertia, and its inability to organize itself into an effective instrument to meet the changing healthcare needs of all veterans under its care. Both service-connected and non-service-connected veterans have experienced a consistent unavailability of access to DVA health care, including mental health, outpatient contract, and inpatient care. Issues of access involve the need for many veterans to travel long distances to obtain care, as occurs with veterans living in rural communities or on island communities in Puerto Rico, the U.S. Virgin Islands, and Hawaii. Non-U.S. citizen veterans of the U.S. Armed Forces may receive DVA treatment for service-connected disabilities only if residing in the U.S. The statute allows payment for the treatment of service-connected disabilities outside the U.S. for veterans of the U.S. Armed Forces, only if such veterans are U.S. citizens, reside in the Republic of the Philippines, or are Canadian nationals. The quality of health care in DVA remains suspect as revelations of questionable practices and adverse outcomes continue to emerge. DVA has lost sight of its obligation to provide quality health care as defined by veterans and their families, opting instead for quality as defined by health administrators and medical school affiliations. Resolved, That: Vietnam Veterans of America maintains that veterans who have sustained injuries or illnesses during and/or as a result of their military service have the right to the highest quality medical and psychological services for treatment of those injuries and illnesses.
The first priority of the DVA must be to provide the highest quality evidence-based medical and psychological treatment at no cost to veterans for illnesses and injuries incurred during and/or as a result of their military service. Therefore, it is the obligation of the Veterans Health Administration (VHA) to fulfill its affirmative responsibility to treat diseases, illnesses and conditions that have been diagnosed in veterans under its care. DVA must insure that the highest quality evidence-based care is provided in DVA healthcare facilities. Monitoring activities conducted by Quality Assurance Programs must be scientifically based and include regular and consistent review by the Under Secretary for Health, Deputy Under Secretaries for Health, VISN Directors, and the director and chief of staff of the institution. Quality data should be easily available to the public. When DVA cannot provide the highest quality care within a reasonable distance or travel time from a veterans’ home (fifty miles) and in a timely manner (thirty days), DVA must provide care via fee-basis provider of choice for service-disabled veterans. Additionally, DVA must provide beneficiary travel reimbursement at the government rate. DVA should report at least annually on the use and cost of fee basis and contract care, including the type of care and the reasons DVA could not provide it. Congress should remove restrictions against providing DVA medical care to non-citizen, service-connected disabled veterans of the U.S. Armed Forces in order to treat equitably all those who served in the U.S. Armed Forces regardless of their country of origin, citizenship, or current country of residence. DVA healthcare policies must allow the veteran client to have input in VA Medical Center/Outpatient Clinic operations. This should include establishment of veterans’ advisory boards at the local level. DVA should report on how many facilities have such boards, how often the boards meet, how members are selected, and how meetings are publicized in the community and among veterans’ service organizations. DVA healthcare policies must be based on patient needs. Healthcare implementation should be decentralized to the local level, and budgeting should allow local facilities to plan for their own needs with significant consultation by the local veterans’ advisory board. Congress must enact and the President must sign into law legislation that creates an assured reliable funding stream for DVA healthcare programs, indexed to medical inflation and the per capita use of the DVA Health Care System. VVA vigorously opposes any philosophy or language that would limit the delivery of the VA healthcare treatment and services to only a small group of veterans in order to save money. VVA is committed to protecting the rights of veterans and access to DVA programs and services as defined in title 38 US Code. Additionally, to maintain medical competency and expertise in the provision of healthcare services, the DVA healthcare system needs to maintain a critical mass of patients if it is to continue as a highly cost-effective integrated managed care system. VVA vigorously resists any attempt to degrade this system by eliminating eligibility for “Priority 7” and “Priority 8” veterans – veterans who do not have service-connected health conditions and who agree to modest co-payments for their care. Furthermore, VVA wants to go on record as applauding the DVA Secretary, General Eric K. Shinseki, for his initiative and commitment to achieve greater transparency by posting information about quality issues in DVA medical centers and community-based outpatient clinics. VETERANS WITH HIV INFECTION History: First adopted in 1987 as V-2-87 Amended and renumbered in 1991 as V-23-91 Amended and renumbered in 1993 as V-6-93 Amended and renumbered in 1995 as V-3-95 Amended in 1997 as V-3-97 Renumbered in 2003 as HC-2-03 Renumbered in 2005 as HC-2-95 Renumbered in 2007 as V-2-95 Renumbered in 2009 as HC-3-09 Renumbered in 2011 as HC-3 Issue: Care of veterans with HIV infection, education and counseling services of veterans and their families regarding the prevention of HIV infection. Background: Human Immunodeficiency Virus (HIV) infection remains a major health issue in the U.S. Approximately six to seven percent of all persons with AIDS in the U.S. are cared for in Department of Veterans Affairs (DVA) medical facilities, and many other veterans receive care for HIV infection/AIDS elsewhere. Resolved, That: Vietnam Veterans of America takes the following position: Urges DVA to continue making available educational materials reflecting the latest research and developments in HIV care for both staff and patients at all DVA medical centers, outpatient clinics, Vet Centers, and Regional Offices. Urges DVA to ensure currently recommended treatments for HIV are available to veterans in DVA facilities or through fee basis or contract care. Continues its commitment to serving veterans with HIV infection through its service Representatives. PROSTATE CANCER RESEARCH AND TREATMENT
History: First adopted as V-18-01 in 2001 Renumbered as HC-5-03 in 2003 Renumbered and amended as HC-18-05 in 2005 Amended and renumbered as V-18-05 in 2007 Amended and renumbered in 2011 as HC-5 Issue: Prostate cancer afflicts over 200,000 American men each year and over 30,000 lives are lost. Studies indicate individuals exposed to Agent Orange present at a younger age, have higher Gleason scores, and have a greater likelihood of developing metastasis than their unexposed counterparts. Background: The Department of Veterans Affairs (VA) has determined that a presumption of service-connection based on exposure to herbicides while in military service is warranted for prostate cancer.
Resolved, That:
Vietnam Veterans of America calls upon the VA Under Secretary for
Health to establish a National Vietnam Veterans Prostate Cancer Protocol to be implemented at all VA facilities. This protocol must include provisions for a) comprehensive outreach and education for the Vietnam veteran population and all VA healthcare providers to the increased risk for prostate cancer; b) utilization of a complete military history as a standard assessment tool for all veterans; c) appropriate, timely and effective early detection screening and treatment; d) judicious monitoring of baseline changes; and e) the development of a “best practices model” which incorporates emerging evidence-based technology and treatment modalities. Vietnam Veterans of America urges that federal funding for prostate cancer research, treatment, and therapies at NIH, DoD, and VA be increased; that the Congress and the Administration re- double efforts to find a cure for prostate cancer; and that the Veterans Health Administration increase its investment in prostate cancer clinical research, improving and accelerating clinical trials at VA hospitals and affiliated university medical centers and research programs. MILITARY HEALTH CARE History: First adopted in 1993 as V-14-93 Renumbered in 2003 as V-4-03 Renumbered in 2005 as V-7-95 Renumbered in 2009 as VB-21-09 Amended and renumbered in 2011 as HC-6 Issue: Upholding individual rights and traditional patient-centered ethics within the Department of Defense (DoD) medical-care system. Background: During Operation Desert Storm concerns were raised by requests from the DoD to the Food and Drug Administration (FDA) to obtain waivers for the administration of unlicensed drugs without informed consent. Although both of the drugs in question (pyridostigmine, for the pre-treatment of organophosphate nerve-agent intoxication, and botulinum-toxoid vaccine) have been used either for the licensed treatment of other conditions or with informed consent, and are known to be safe, the general concept of blanket waivers raises the specter of previous drug and chemical experiments conducted by the military. The issue of consent in a war zone is complex as some might choose to use failure to consent as an excuse for removing themselves from the dangers of a war zone. Conversely, requiring an unvaccinated or untreated individual to remain in a danger zone when use of chemical or biological warfare is anticipated also is unethical. Also of concern is whether or not military medical personnel are primarily responsible for the health and well-being of those under their care if they must subordinate the medical interests of individual patients to the military mission. While the treatment of multiple casualties often requires prioritizing the use of personnel and material resources by triaging patients, the care provided by military medical personnel should adhere to the same standards of medical care and medical ethics required by state licensing boards.
In 1999, President Clinton signed Executive Order 13139 which provides some controls on the use of investigational new drugs or drugs which have not yet been approved by FDA for their intended use. Under this Executive Order, which is still in effect, only the President of the United States may waive informed consent requirements on the grounds that obtaining consent is 1) not feasible; 2) contrary to the best interests of the service members; or 3) not in the interests of national security. The Executive Order requires that the Secretary of Defense submit a plan for tracking use and adverse effects of the investigational drug(s) as a part of the waiver request and for notifying military personnel receiving the investigational drug(s). If granted, the waiver must be communicated to Congress and a public notice printed in the Federal Register. Waivers, when granted, will expire after no more than one year but can be renewed using the same procedures required for an original waiver. Resolved, That: Vietnam Veterans of America takes the following positions: 1. Affirms its support for requiring fully informed consent of military personnel, even in wartime, for the use of experimental and investigational drugs;
2. Calls on the DoD to develop a policy stating the ethical responsibilities of military medical personnel as well as all military leaders, and to develop a patient’s bil of rights similar to that adopted by Department of Veterans Affairs (VA); and 3. Affirms its belief in leadership by example and that everyone in the theater of operations from the Commanding General on down should be subject to the same immunization requirements/protocols. PARTICIPATION IN THE PROCESS OF ACCREDITING VA MEDICAL CENTERS History: First adopted in 1993 as V-13-93 In 1995 renumbered as V-6-95 In 2003 renumbered as V-3-03 In 2009 renumbered as VB-20-09 Amended and renumbered in 2011 as HC-7 Issue: Consumer input into the accreditation process. Background: The Joint Commission on Accreditation of Health Care Organizations (JCAHO accredits hospitals and other health-care facilities in the U.S. Although a private nonprofit organization, JCAHO, with input from professional and consumer groups, establishes the standards by which health-care facilities are evaluated. Accreditation status is used to establish eligibility for non-federal institutions to receive Medicare funds and, in some cases, to determine
eligibility for licensure. Although Department of Veterans Affairs (VA) facilities can continue operating without accreditation, all VA Medical Centers (VAMCs) participate in the JCAHO accreditation process, and loss of accreditation or conditional accreditation is viewed as an extremely serious matter by VA Central Office management. The Commission on Accreditation of Rehabilitation Facilities (CARF) similarly accredits specific programs within VA facilities. Examples of programs that may be accredited by CARF include: medical rehabilitation; DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies); behavioral health; opioid treatment; and employment services.
Both the JCAHO and CARF reviews are conducted at least every three years and include on- site visits to the healthcare facility. Accrediting agencies require that the facility provide an opportunity for the presentation of information by consumers and the public. Anyone who has information about a hospital’s compliance with the accreditation standards may request a public- information interview using the procedure established by the accrediting agency. Both JCAHO and CARF post a searchable list of accredited programs on their websites. Resolved, That: Vietnam Veterans of America takes the following positions: 1. Encourages chapters and state councils to become familiar with the accreditation standards currently used by JCAHO and CARF; 2. Encourages chapters and state councils to participate appropriately in providing consumer input, both positive and negative, during accreditation surveys by requesting public information interviews; and 3. Will act to ensure that veterans’ service organizations are informed and encouraged to participate in accreditation processes at VA medical facilities.
HOURS OF OPERATION OF VA MEDICAL FACILITIES History: First adopted in 1993 as V-17-93 In 1995 renumbered as V-10-95 In 1997 renumbered as V-9-97 In 2003 renumbered as V-6-03 In 2005 renumbered as V-9-95 In 2009 renumbered as VB-23-09 Amended and renumbered in 2011 as HC-9 Issue: Accessibility and timeliness of health care at Department of Veterans Affairs (VA) facilities. Background: The hours of operation for outpatient care at many VA hospitals and clinics are generally from 8-9 a.m. to 4-5 p.m. Veterans who are employed or have personal responsibilities may find it difficult to make appointments during these hours. Saturday
and evening clinics, as well as measures to decrease waiting times, would facilitate use of VA facilities by these veterans. Resolved, That: Vietnam Veterans of America
1. Encourages all VA hospitals and clinics to provide weekend and evening appointments
for veterans through use of flexible employee scheduling;
2. Encourages hospitals and clinics to diligently evaluate and improve scheduling to
3. Will establish metrics to determine if VA medical facilities are being flexible in their hours of operation in order to meet the changing needs of an evolving veteran population. DEPARTMENT OF VETERANS AFFAIRS RESEARCH
History: First adopted in 2011 as HC-10 Issue: Research funded by the Department of Veterans Affairs (VA) too often does not address the needs and interests of the veterans it serves. Background: Areas of importance for include the efficacy of various PTSD treatment modalities for different populations; long-term consequences of PTSD, Traumatic Brain Injury (TBI), infectious diseases endemic to areas where the U.S. military serves; and the efficacy of long-term care options for aging veterans. Resolved, That: Vietnam Veterans of America urges that the Secretary of Veterans Affairs direct the Office of Research and Development and the various Research, Education, and Clinical Centers to focus on the wounds, maladies, injuries, and traumas of military service and war, research targeted to issues unique to specific wars and deployments. TESTING FOR HEPATITIS C
History: First adopted in 2011 as HC-11 Issue: Vietnam Veterans are known to have a significant higher prevalence of Hepatitis C than non-veterans of the same generation. Background: Not all Veterans Affairs facilities are ensuring that all Vietnam-era veterans are offered testing for Hepatitis C. Resolved, That: Vietnam Veterans of America request that the Secretary of Veterans Affairs ensure all Veterans Health Administration (VHA) facilities comply with existing VHA Hepatitis C
protocols, that all Vietnam-era patients are offered the blood test for Hepatit6is C and, if the test is positive, be accorded appropriate follow-up and treatment.
Regulations Regarding Restrictions in the Use of Medicinal Products on Animals and the Requirements for the Circulation of Animals and Products of Animal Origin if Medicinal Products are Used on Animals Issued pursuant to Section 5, Clause 11 of the Pharmaceutical Law and Section 25, Clause 1 of the Veterinary Medicine Law I. General Provisions 1. These Regulations prescrib
General Terms and Conditions for Travel Services of Hogg Robinson Germany GmbH & Co. KG Issuing of Information 1.1 The following General Terms and Conditions ( GTC ) represent an integral 3.1 We are committed to placing booking orders with proper care, and to component of the travel agency agreement that is to materialize between provide the Customer (or the person travelling)